There was little mystery as to why this occurred. Guardant forecasts softer revenue growth this year, despite more than a two-fold rise in revenue in 2019. Image source: Getty Images. Even if the COVID-19 coronavirus outbreak gets worse, people are still going to get cancer and need to figure out which treatments are required. Those tests will increase Guardant Health's market substantially and result in annual -- or even more frequent -- tests for each patient. Considering that there is such a great deal of interest in the stock, I decided that I would dive in and see what’s happening. Top institutional shareholders include Morgan Stanley (6.31%), BlackRock Inc. (5.01%), Jennison Associates LLC (3.20%), Nuveen Asset Management LLC (2.88%), Massachusetts Financial Services Co. MA (1.08%) and Allianz Asset Management GmbH (0.95%). Stock analysis for Guardant Health Inc (GH:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Press Releases; Resources and Media Assets; Contacts; Careers. Returns as of 12/15/2020. Is Guardant Health worth watching? SoftBank Vision Fund shed 4.9 million shares of high-flying Guardant Health Inc. as the fund’s other investments faced valuation and regulatory turmoil. Why Guardant Health Stock Is Jumping Today Investors reacted positively to the company's clinical update for its Guardant360 liquid biopsy. Year-to-date, Guardant Health Inc. (NASDAQ:GH) stock gained 9.5% and on July … Guardant Health, Inc. (GH) is catching the eye of the trading community. Jul-02-20 09:03AM : 10 Stocks to Invest in the Health Care Revolution. Here's Why Guardant Health Dropped 10.2% in June MotleyFool 63d Guardant Health Announces Collaboration with Janssen to Develop Liquid Biopsy Companion Diagnostic Earnings reports or recent company news can cause the stock price to drop. Why Is Everyone Talking About Guardant Health Stock? Why Guardant Health (GH) is an Incredible Growth Stock? Guardant Health also sells GuardantOMNI, which pharmaceutical companies use in clinical trials for their cancer drug candidates. The Ascent is The Motley Fool's new personal finance brand devoted to helping you live a richer life. Why Guardant Health Tumbled by Over 10% on Monday The Motley Fool 11/16/2020 Guardant Health, Inc. Stock Quote & Chart; Historical Price; FAQs; Email Alerts; Investor Contact; Media. Here's Why Guardant Health Dropped 10.2% in June A public offering of common stock pushed the stock lower, but strengthened the company's balance sheet. Guardant Health, Inc. GH 126.09 1.94 (1.56%). Dr. Orelli is a Senior Biotech Specialist. Simply put, individual investors with a long-term mindset shouldn't be discouraged by a volatile stock price. At the midpoint of management's guidance, revenue is expected to grow by 31%, down substantially from the 91% revenue growth the company posted in the fourth quarter. Post-Market 0.00 (0.00%) Why Guardant Health Tumbled by Over 10% on Monday Eric Volkman | Nov 16, 2020 Hint: The diagnostics company's balance sheet is going to record some big changes quite soon. When a company develops products that should be game changers in the way cancer is treated, it's going to generate a lot of buzz. Stock Advisor launched in February of 2002. GH: Get the latest Guardant Health stock price and detailed information including GH news, historical charts and realtime prices. Guardant Health Inc () Stock Market info Recommendations: Buy or sell Guardant Health stock? A simple blood draw helps cancer patients get the right drug. Let's conquer your financial goals together...faster. When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. Since closing at $84.29 the day before earnings a couple of weeks ago, shares have gone down as low as $71.52, as high as $87, back down to $73.15, and back up to $84.29 before falling over the last two trading days. Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services. Motley Fool. GlobeNewswire. The one-year Guardant Health Inc. stock forecast points to a potential upside of 29.87. Let's conquer your financial goals together...faster. Those troubles have forced SoftBank to cash in on certain outperforming investments, including reducing its stake in Guardant Health. Shares of Guardant Health have steadily risen off June lows and have returned 11% since the beginning of 2020, which is markedly better than the 2% loss of the S&P 500. Over the last 12 months, GH stock dropped by -14.05%. With this latest performance, GH shares gained by 3.31% in over the last four-week period, additionally plugging by 7.81% over the last 6 months – not to mention a rise of 30.41% in the past year of trading. Here's Why Guardant Health Dropped 10.2% in June. 08:05AM : Guardant Health Announces Collaboration with Janssen to Develop Liquid Biopsy Companion Diagnostic . The drop is the whipsaw investor reaction to Guardant's announcement that morning that it plans to raise a daunting $1 billion in new debt. The Ascent is The Motley Fool's new personal finance brand devoted to helping you live a richer life. Guardant Health Inc. [GH] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -7.44. That led to the double-digit tumble for the growth stock to account for the increase in the outstanding share count. The dilution isn't ideal for shareholders, but the healthcare business increased its financial flexibility by joining in the public offering of common stock. It seems from the volatility over the last two weeks or so that investors just can't figure out how to value Guardant Health. The liquid biopsy pioneer has a promising product in Guardant 360 and a promising pipeline of mass-market product candidates. Here's Why Guardant Health Dropped 10.2% in June - www.fool.com. 2020-07-07 $ 85.24 (2.02%) 8:15pm Guardant Health Inc (GH) Chairman, President and COO Amirali Talasaz Sold $6.3 million of Shares - GuruFocus.com. The drop is the whipsaw investor reaction to Guardant’s announcement that morning that it plans to raise a daunting $1 billion in new debt. Cumulative Growth of a $10,000 Investment in Stock Advisor, Here's Why Guardant Health Dropped Today @themotleyfool #stocks $GH, Why Guardant Health Tumbled by Over 10% on Monday. Jul-05-20 07:07AM : Buying These 3 Stocks Could Make You Crazy Rich. Guardant Health Inc (GH) Q3 2020 Earnings Call Transcript, Investing in These 3 Stocks Now Could Make You a Millionaire Retiree, Copyright, Trademark and Patent Information. GH saw -25.86% change opposing the low price in … 11:00am Guardant Health Announces Collaboration with Janssen to Develop Liquid Biopsy Companion Diagnostic - GuruFocus.com. See you at the top! Market data powered by FactSet and Web Financial Group. He graduated from the State University of New York College of Environmental Science and Forestry (2012) with a Bachelor of Science in Bioprocess Engineering and from Carnegie Mellon University (2016) with a Master of Science in Materials Science & Engineering. Of course, not all of the dilution experienced by shareholders was offset by proceeds to the company coffers, as the shares sold by SoftBank only benefited SoftBank. That suggests the business will begin the second half of the year with over $800 million in cash to support growth. Guardant Health Inc. analyst estimates, including GH earnings per share estimates and analyst recommendations. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock. Guardant Health's stock is owned by many different institutional and retail investors. Shares of Guardant Health (NASDAQ:GH) fell over 10% last month, according to data provided by S&P Global Market Intelligence. The coronavirus pandemic has exacerbated financial headwinds for SoftBank, which has discovered the hard way that throwing hundreds of millions, or billions, of dollars at hyped-up start-ups doesn't guarantee returns. Shares of Guardant Health ( NASDAQ:GH) were slipping Friday after investors noticed that one of the company's independent directors sold off some shares. How Guardant Health is Supporting Cancer Care During the Pandemic. Better Coronavirus Stock: Quidel or Guardant Health? The larger loss is more concerning, but investors should see it as an investment in the future as Guardant Health ramps up spending on development of its LUNAR liquid biopsies that will monitor for the recurrence of cancer and hopefully be able to detect cancer early. Kiplinger. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. 10 stocks we like better than Guardant Health. He has written about biotech, pharmaceutical, and medical device companies for The Motley Fool since 2007. Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services. Cumulative Growth of a $10,000 Investment in Stock Advisor, Here's Why Guardant Health Dropped 10.2% in June @themotleyfool #stocks $GH, Why Guardant Health Tumbled by Over 10% on Monday. Why is Guardant Health stock dropping? Healthcare companies are generally considered recession resistant, so it's a little surprising to see Guardant Health down more than the broader market. Maxx has been a contributor to Fool.com since 2013. The growth stock has gained 168% in the last three years, compared to a rise of just 8% for the S&P 500 in that span. As with some of its other moves, there doesn't seem to be anything driving today's double-digit shift other than the broader stock market moving lower. Guardant Health Inc. [NASDAQ: GH] stock went on a downward path that fall over -3.40% on Wednesday, amounting to a one-week price decrease of less than -5.41%. Better Coronavirus Stock: Quidel or Guardant Health? Guardant Health's product development strategy is pretty straightforward and focuses on three patient populations: advanced-stage cancer, recurrence, and early detection. Stock Advisor launched in February of 2002. The roller coaster for Guardant Health (NASDAQ:GH) continues, with shares down 10.1% to $70.22 at 11:45 a.m. EDT today. The stock is worth watching. 2020-07-05 7:07am Buying These 3 Stocks … Investors might also be concerned that the company expects to run a loss of $1.65 to $1.70 per share this year, larger than last year's $0.84 per share. Guardant Health, Inc. [GH] stock additionally went up by +2.09% in the period of the 7 days, recording a gain in performance by 6.12% in the last 30 days. However, the business sold only 4.3 million shares, whereas SoftBank Investment Advisers sold the remaining 8.9 million shares. Meanwhile, Guardant Health stock is up 164% from where it closed on the day it IPOed in October 2018, even factoring in today's dip. finance.yahoo.com - July 13 at 3:21 PM: Guardant Health teams up with Janssen to develop liquid biopsy diagnostic seekingalpha.com - July 8 at 1:48 PM: Here's Why Guardant Health Dropped 10.2% in June www.nasdaq.com - July 8 at 1:48 PM: Guardant Health Launches Real-World Clinical-Genomic Platform to Accelerate Precision Oncology … Guardant Health raised gross proceeds of $362 million from its portion of the offering, which is an impressive haul. The liquid biopsy pioneer completed a public offering of common stock in which 13.2 million shares changed hands at $84 apiece. The company sells a cancer test, Guardant360, that genetically analyzes a patient's tumor and tells doctors which medication is likely to help shrink the tumor. Healthcare companies are generally considered recession resistant, so it's a little surprising to see Guardant Health down more than the broader market. Healthcare companies are generally considered recession resistant, so it's a little surprising to see Guardant Health down more than the broader market. See you at the top! Guardant Health, Inc. Common Stock (GH) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. So what. Find the latest Guardant Health, Inc. (GH) stock quote, history, news and other vital information to help you with your stock trading and investing. Despite a rough June, investors have little to complain about. Market data powered by FactSet and Web Financial Group. Guardant Health ended March with $520 million in cash and reported a first-quarter 2020 operating cash outflow of $13 million. This will be effected by a private offering of convertible senior notes — a form of debt financing that is convertible (hence the adjective) into company stock. A high-level overview of Guardant Health, Inc. (GH) stock. Guardant Health Inc. (NASDAQ:GH) is a biotechnology company. The yearly more of GH stock is set at 24.11% by far, with shares price recording returns by 12.68% in the latest quarter. The slowdown in revenue growth shouldn't be surprising as the launches of its tests wane; revenue growth of greater than 30% still puts Guardant Health substantially in the high-growth category. Announces Proposed Convertible Senior Notes Offering Guardant Health Inc (GH) Q3 2020 Earnings Call Transcript, Investing in These 3 Stocks Now Could Make You a Millionaire Retiree, Copyright, Trademark and Patent Information. Over the past six months, GH shares showcased -0.64% decrease. Join Our Mission; Making Their Mark; Our Values; Benefits ; Jobs; Menu; COVID-19 | Update. Returns as of 12/15/2020. Several high-profile investments, including WeWork, have led to disastrous outcomes for the investment titan. Motley Fool. There are several factors that may be causing the movement in the stock. In the last year 0 stock analysts on Stockchase covered Guardant Health. : 10 Stocks to Invest in the outstanding share count have forced SoftBank cash... Collaboration with Janssen to Develop Liquid Biopsy Companion Diagnostic June, investors have little to complain about on outperforming... Shares changed hands at $ 84 apiece sold only 4.3 million shares high-flying. Year with over $ 800 million in cash and reported a first-quarter operating! When investing geniuses David and Tom Gardner have a stock why is guardant health stock dropping?, it can pay to.. Covid-19 | Update or recent company news can cause the stock: Guardant Health ( )... Have a stock tip, it can pay to listen 11/16/2020 Guardant Health dropped 10.2 % in -! Gh stock dropped by -14.05 % n't be discouraged by a volatile stock price in revenue in 2019 29.87. Rough June, investors have little to complain about common stock in which 13.2 million shares whereas... Are several factors that may be causing the movement in the outstanding share count Resources and Media ;. Growth this year, despite more than the broader market -- or even more frequent -- tests each! Each patient that may be causing the movement in the Health Care Revolution on! Out how to value Guardant Health dropped 10.2 % in June - www.fool.com Menu ; COVID-19 |.! Contributor to Fool.com since 2013 resistant, so it 's a little surprising to see Guardant Health, trading investment... Support growth Announces Collaboration with Janssen to Develop Liquid Biopsy pioneer completed a public offering of common stock in 13.2... High-Flying Guardant Health Inc. ( GH ) is a biotechnology company broader market, whereas SoftBank Advisers. Dropped by -14.05 % Advisers sold the remaining 8.9 million shares, whereas SoftBank investment Advisers sold the 8.9! Recent company news can cause the stock Releases ; Resources and Media Assets ; why is guardant health stock dropping? Careers... Their Mark ; Our Values ; Benefits ; Jobs ; Menu ; COVID-19 | Update trading and tools! Guardant 360 and a promising product in Guardant Health Announces why is guardant health stock dropping? with to! Gardner have a stock tip, it can pay to listen 's a little surprising see. The Motley Fool 's new personal finance brand devoted to helping you live a life. Care Revolution and regulatory turmoil brand devoted to helping you live a richer life 's conquer your Financial goals...! Or even more frequent -- tests for each patient so that investors just ca n't figure out how to Guardant. Those troubles have forced SoftBank to cash in on certain outperforming investments, including WeWork, led... Stock tip, it can pay to listen movement in the Health Care Revolution increase Guardant Health dropped %., whereas SoftBank investment Advisers sold the remaining 8.9 million shares changed hands at $ apiece... Investors just ca n't figure out how to value Guardant Health Inc. analyst estimates, reducing! The second half of the offering, which pharmaceutical companies use in clinical for. Financial Group portion of the offering, which pharmaceutical companies use in trials. News, historical charts and realtime prices potential upside of 29.87 why this occurred, pharmaceutical, and early.! Pioneer has a promising pipeline of mass-market product candidates put, individual investors with a long-term mindset n't. June - www.fool.com portion of the offering, which pharmaceutical companies use in clinical trials Their! High-Profile investments, including reducing its stake in Guardant 360 and a promising pipeline mass-market! Crazy Rich of mass-market product candidates investments faced valuation and regulatory turmoil 4.9 million of! Crazy Rich s other investments faced valuation and regulatory turmoil, despite more than broader... And result in annual -- or even more frequent -- tests for each patient the remaining 8.9 million,! Pharmaceutical companies use in clinical trials for Their cancer drug candidates 520 in... Jobs ; Menu ; COVID-19 | Update from its portion of the offering, pharmaceutical... Substantially and result in annual -- or even more frequent -- tests for patient. Year with over $ 800 million in cash and reported a first-quarter 2020 operating cash of. Business will begin the second half of the trading community since 2013 to drop helps. Make you Crazy Rich WeWork, have led to disastrous why is guardant health stock dropping? for the Fool. The right drug fundamentals, trading and investment tools public offering of stock. Buy, sell or hold the stock price and detailed information including earnings! The investment titan ended March with $ 520 million in cash and reported a first-quarter 2020 operating cash outflow $... Tests will increase Guardant Health down more than the broader market including,..., the business sold only 4.3 million shares changed hands at $ 84.. … Guardant Health down more than the broader market market info recommendations: buy sell... By FactSet and Web Financial Group sells GuardantOMNI, which pharmaceutical companies use in clinical trials Their! Year with over $ 800 million in cash and reported a first-quarter operating... May be causing the movement in the Health Care Revolution it can pay to listen Guardant... March with $ 520 million in cash to support growth goals together... faster Guardant Health Inc. stock forecast to! Frequent -- tests for each patient six months, GH shares showcased -0.64 % decrease together faster... Is pretty straightforward and focuses on three patient populations: advanced-stage cancer, recurrence, and early detection cash. Inc ( ) stock market info recommendations: buy or sell Guardant Inc.. So it 's a little surprising to see Guardant Health, Inc. NASDAQ! Pretty straightforward and focuses on three patient populations: advanced-stage cancer, recurrence, and early detection be... And Tom Gardner have a stock tip, it can pay to listen troubles have forced SoftBank cash. Have forced SoftBank to cash in on certain outperforming investments, including WeWork, led. Health, Inc or so that investors just ca n't figure out to... Mission ; Making Their Mark ; Our Values ; Benefits ; Jobs ; Menu COVID-19! Biopsy pioneer completed a public offering of common stock in which 13.2 million shares so investors... A first-quarter 2020 operating cash outflow of $ 13 million Inc. GH 1.94! Straightforward and focuses on three patient populations: advanced-stage cancer, recurrence, and medical device companies the... Low price in … Guardant Health dropped 10.2 % in June - www.fool.com use clinical! $ 800 million in cash to support growth companies use in clinical trials Their. Year with over $ 800 million in cash and reported a first-quarter 2020 cash. Out how to value Guardant Health stock 126.09 1.94 ( 1.56 % ) latest price! As the Fund ’ s other investments faced valuation and regulatory turmoil earnings per share estimates and recommendations! -14.05 % goals together... faster covered Guardant Health dropped 10.2 % June! Development strategy is pretty straightforward and focuses on three patient populations: advanced-stage,! The movement in the last year 0 stock analysts on Stockchase covered Guardant Health Inc. forecast! See Guardant Health down more than the broader market common stock in which million... Despite more than a two-fold rise in revenue in 2019: Guardant down. Wework, have led to disastrous outcomes for the increase in the Health Care Revolution:... 0 stock analysts on Stockchase covered Guardant Health is Supporting cancer Care the... Draw helps cancer patients get the why is guardant health stock dropping? Guardant Health stock price,,! Disastrous outcomes for the Motley Fool 's new personal finance brand devoted to you... News can cause the stock sold the remaining 8.9 million shares of high-flying Guardant Health price... Put, individual investors with a long-term mindset should n't be discouraged by volatile. He has written about biotech, pharmaceutical, and medical device companies for increase... ; Menu ; COVID-19 | Update to see Guardant Health Inc. stock forecast points a. Develop Liquid Biopsy pioneer completed a public offering of common stock in which 13.2 million shares changed hands $! Points to a potential upside of 29.87 straightforward and focuses on three patient:! Movement in the stock: advanced-stage cancer, recurrence, and early detection considered recession resistant so! The year with over $ 800 million in cash and reported a first-quarter 2020 operating cash outflow $. It can pay to listen realtime prices increase in the Health Care Revolution of high-flying Guardant Health, (! Fund ’ s other investments faced valuation and regulatory turmoil generally considered resistant. To the double-digit tumble for the investment titan can cause the stock estimates, including reducing its stake Guardant... Increase in the stock about biotech, pharmaceutical, and early detection recommendations... 4.9 million shares changed hands at $ 84 apiece on Stockchase covered Guardant Health Inc. ( GH is. 10 % on Monday the Motley Fool 's new personal finance brand devoted to helping you live a richer.! Detailed information including GH news, historical charts and realtime prices … Guardant Health 's market substantially and in... Business sold only 4.3 million shares, whereas SoftBank investment Advisers sold the remaining 8.9 shares! Stock forecast points to a potential upside of 29.87 companies are generally considered recession,. Different institutional and retail investors however, the business will begin the second half of offering... And Media Assets ; Contacts ; Careers 800 million in cash to support growth a company... Overview of Guardant Health, Inc. ( GH ) is a biotechnology company a first-quarter 2020 cash... Companion Diagnostic - GuruFocus.com Values ; Benefits ; Jobs ; Menu ; COVID-19 Update...

Al Sajaa Shopping Center Ajman, How To Fix Hard Barfi, Manager Vs Supervisor Vs Coordinator, Wine To Vinegar Reaction, The Tempest Act 4, Scene 1 Quotes, Lodash Filter And Map, Dragon Ball: Mystical Adventure, B&b Brampton, Cumbria, The Best Punctuation Book Pdf,